Trials / Recruiting
RecruitingNCT04296604
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Detailed description
In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain. The investigators will select 8 relevant diagnostic categories: traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorder. The study will also include a cohort of healthy controls for comparison.
Conditions
- Traumatic Brain Injury
- Major Depressive Disorder
- Bipolar Disorder
- Schizophrenia
- Attention Deficit Hyperactivity Disorder
- Borderline Personality Disorder
- Substance Use Disorders
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Direct Current Stimulation | In tDCS, electrodes are applied on the scalp to transmit direct current at low current amplitudes. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2020-03-05
- Last updated
- 2025-09-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04296604. Inclusion in this directory is not an endorsement.